氨甲环酸在袖状胃切除术中减少出血的双盲随机对照试验
本研究为双盲随机对照试验,纳入101例初次袖状胃切除术患者,随机接受术中1500 mg氨甲环酸或安慰剂。主要结局止血夹使用无显著差异,但氨甲环酸组血红蛋白变化、心率、轻微并发症和住院时间有改善,无静脉血栓事件或死亡。
要点
- 术中氨甲环酸未显著减少止血夹使用。
- 氨甲环酸组轻微并发症和住院时间更优。
- 未增加静脉血栓事件风险。
核心结论
- 术中氨甲环酸未显著减少止血夹使用和重大并发症,但对临床参数、轻微并发症和住院时间有积极影响,且不增加静脉血栓事件风险。
研究设计与样本
- 双盲随机对照试验,在高容量减重医院纳入101例初次袖状胃切除术患者,1:1随机接受1500 mg氨甲环酸(n=49)或安慰剂(n=52)。
主要发现
- 止血夹使用率两组分别为69%和83%,差异无统计学意义(p=0.161)。
- 血红蛋白变化(毫摩尔/升)分别为0.55和0.80(p=0.013),心率变化(次/分)分别为-4.6和2.5(p=0.013)。
- 轻微并发症(Clavien-Dindo≤2)发生率分别为2.0%和17.3%(p=0.016),平均住院时间(小时)分别为30.8和36.7(p=0.013)。
- 安慰剂组1例因术后出血接受放射学干预,未报告静脉血栓事件或死亡。
关键数值与推荐
- 术中给予1500 mg氨甲环酸。
- 主要结局为术中止血夹加固使用。
- 次要结局包括纤维蛋白密封剂使用、失血量、术后血红蛋白、心率、疼痛、并发症、住院时间、静脉血栓事件和死亡。
临床怎么用
- 袖状胃切除术中可考虑使用氨甲环酸以减少轻微并发症和缩短住院时间,但需更大样本研究验证对重大并发症的影响。
局限性
- 样本量较小(101例),需更大规模研究探讨氨甲环酸对术后重大并发症的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In metabolic surgery, hemorrhage is the most common major complication. This study investigated whether peroperative administration of tranexamic acid (TXA) reduced the risk of hemorrhage in patients undergoing laparoscopic sleeve gastrectomy (SG). METHODS: In this double-blind randomized controlled trial, patients undergoing primary SG in a high-volume bariatric hospital were randomized (1:1) to receive 1500-mg TXA or placebo peroperatively. Primary outcome measure was peroperative staple line reinforcement using hemostatic clips. Secondary outcome measures were peroperative fibrin sealant use and blood loss, postoperative hemoglobin, heart rate, pain, major and minor complications, length of hospital stay (LOS), side effects of TXA (i.e., venous thrombotic event (VTE)) and mortality. RESULTS: In total, 101 patients were analyzed and received TXA (n = 49) or placebo (n = 52). There was no statistically significant difference in hemostatic clip devices used in both groups (69% versus 83%, p = 0.161). TXA administration showed significant positive changes in hemoglobin levels (millimoles per Liter; 0.55 versus 0.80, p = 0.013), in heart rate (beats per minute; -4.6 versus 2.5; p = 0.013), in minor complications (Clavien-Dindo ≤ 2, 2.0% versus 17.3%, p = 0.016), and in mean LOS (hours; 30.8 versus 36.7, p = 0.013). One patient in the placebo-group underwent radiological intervention for postoperative hemorrhage. No VTE or mortality was reported. CONCLUSION: This study did not demonstrate a statistically significant difference in use of hemostatic clip devices and major complications after peroperative administration of TXA. However, TXA seems to have positive effects on clinical parameters, minor complications, and LOS in patients undergoing SG, without increasing the risk of VTE. Larger studies are needed to investigate the effect of TXA on postoperative major complications.
引用
- 't Hart JWH, Noordman BJ, Wijnand JMA, et al. Peroperative administration of tranexamic acid in sleeve gastrectomy to reduce hemorrhage: a double-blind randomized controlled trial. Surg Endosc. 2023. PMID: 37400687. doi:10.1007/s00464-023-10232-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。